Some Apple Watch sales will be halted starting Thursday; stock falls
By Tomi KilgoreJon Swartz
Apple's stock falls for second session, after closing at a record on Dec. 14
Shares of Apple Inc. dropped Monday, after the Wall Street Journal reported the technology giant would halt some Apple Watch sales in a preemptive move to comply with a U.S. import ban regarding the use of blood-oxygen sensors.
The company (AAPL) confirmed to CNN it will no longer be selling its Apple Watch Series 9 and Apple Watch Ultra 2, starting Thursday on Apple.com and from retail locations after Dec. 24.
"While the review period will not end until December 25, Apple is preemptively taking steps to comply should the ruling stand," the company said in a statement, according to the report. "Apple strongly disagrees with the order and is pursuing a range of legal and technical options to ensure that Apple Watch is available to customers."
If the order stands, Apple said it will "continue to take all measures to return Apple Watch Series 9 and Apple Watch Ultra 2 to customers in the U.S. as soon as possible."
The ban, which would include the Apple Watch Series 9 and Apple Watch Ultra 2, comes after the U.S. International Trade Commission found that Apple violated patents in most new models of its smartwatches since 2020, the WSJ report said.
Apple's stock fell 0.85% in trading Monday, to buck the rallies in the technology sector XLK and the broader stock market. SPX
The stock's decline snapped a seven-week win streak in which it has soared 17.4%, and included a record close of $198.11 on Dec. 14.
Apple said it believes the ITC's findings are inaccurate and should be reversed. It said it plans to take the decision to the Federal Circuit.
The commission had found in October that Apple violated medical-technology company Masimo Corp.'s (MASI) patents related to measuring blood-oxygen levels. That led the commission to issue an order to ban the import of certain Apple Watches.
The Biden administration has 60 days to overrule the Trade Commission's order.
Masimo shares rallied 5.5% in afternoon trading Monday.
While Apple didn't provide data on Apple Watch sales in its latest earnings report, it did say wearables, home and accessories revenue came in at $9.3 billion during the fiscal fourth-quarter ended Sept. 30.
Apple's stock, which has eased 1% since closing at a record $198.11 on Dec. 14, has run up 50.9% year to date while the Nasdaq Composite has rallied 42.5% and the Dow Jones Industrial Average has gained 12.6%.
-Tomi Kilgore -Jon Swartz
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-18-23 1650ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth